Safety and Immunogenicity of SUM-101 Malaria Vaccine in Children and Infants Living in Burkina Faso
NCT06618885
·
clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
69
Enrollment
OTHER
Sponsor class
Conditions
Malaria,Falciparum
Interventions
BIOLOGICAL:
SUM-101
Sponsor
European Vaccine Initiative
Collaborators
[object Object]
[object Object]